| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 17, 2023 | PSNL Personalis, Inc. | Moore Stephen Michael52 | General Counsel | Sell | 1,781 | $1.98 | $3,526.38 | -2.1% | -12.6% | -32.6% | |
| May 17, 2023 | FLGT Fulgent Genetics, Inc. | Gao Hanlin73 | Chief Scientific Officer | Sell | 345 | $35.46 | $12,234.49 | - | -4.5% | -37.0% | |
| May 17, 2023 | PSNL Personalis, Inc. | Chen Richard70 | Chief Medical Officer And EVP | Sell | 971 | $1.98 | $1,922.58 | -0.7% | -12.6% | -32.6% | |
| May 16, 2023 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 1,516 | $6.50 | $9,851.73 | -28.2% | -17.3% | +235.3% | |
| May 16, 2023 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 8,685 | $6.50 | $56,439.47 | -35.0% | -17.3% | +235.3% | |
| May 16, 2023 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 8,372 | $23.17 | $193,940.76 | -0.9% | -17.0% | +7.5% | |
| May 15, 2023 | CRL Charles River Laboratories International, Inc. | Laplume Joseph W66 | EVP, Corp Strategy &Develop | Sell | 345 | $190.39 | $65,684.55 | -1.4% | +12.8% | +21.0% | |
| May 15, 2023 | MTD Mettler Toledo International Inc/ | Magloth Christian66 | Head Of Human Resources | Sell | 725 | $1,384.65 | $1,003,870.00 | -31.4% | -10.5% | +7.9% | |
| May 12, 2023 | MTD Mettler Toledo International Inc/ | Vadala Shawn68 | Chief Financial Officer | Sell | 880 | $1,360.61 | $1,197,338.60 | -8.1% | -10.0% | +9.2% | |
| May 12, 2023 | CRL Charles River Laboratories International, Inc. | Laplume Joseph W66 | EVP, Corp Strategy &Develop | Sell | 959 | $193.03 | $185,115.63 | -1.9% | +13.8% | +19.3% | |
| May 11, 2023 | CRL Charles River Laboratories International, Inc. | Massaro George66 | Director | Sell | 288 | $193.43 | $55,707.84 | -5.5% | +10.2% | +16.5% | |
| May 10, 2023 | EXAS Exact Sciences Corp | Condella Sarah75 | EVP, Human Resources | Sell | 6,087 | $80.00 | $486,960.00 | -7.0% | +7.3% | -31.2% | |
| May 10, 2023 | EXAS Exact Sciences Corp | Herriott James75 | General Counsel | Sell | 1,300 | $79.85 | $103,805.00 | -13.2% | +7.3% | -31.2% | |
| May 10, 2023 | EXAS Exact Sciences Corp | Orville Jacob A76 | General Manager, Screening | Sell | 5,000 | $80.00 | $400,000.00 | -43.8% | +7.3% | -31.2% | |
| May 10, 2023 | TWST Twist Bioscience Corp | Cho Dennis70 | See Remarks | Buy | 10,000 | $13.20 | $132,000.00 | +51.8% | +76.6% | +227.0% | |
| May 10, 2023 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 5,000 | $54.06 | $270,318.65 | -0.5% | +2.9% | +86.6% | |
| May 10, 2023 | BDSX Biodesix Inc | Siurek Ryan H64 | Chief Accounting Officer | Sell | 2,020 | $1.57 | $3,169.60 | -2.4% | -2.4% | -5.5% | |
| May 10, 2023 | BDSX Biodesix Inc | O'Kane Kieran64 | Chief Commercial Officer | Sell | 1,697 | $1.57 | $2,662.78 | -2.2% | -2.4% | -5.5% | |
| May 10, 2023 | BDSX Biodesix Inc | Cowie Robin Harper62 | CFO, Sec'y &Treasurer | Sell | 3,485 | $1.57 | $5,468.34 | -1.5% | -2.4% | -5.5% | |
| May 10, 2023 | BDSX Biodesix Inc | Pestano Gary Anthony65 | Chief Development Officer | Sell | 1,527 | $1.57 | $2,396.03 | -0.8% | -2.4% | -5.5% | |
| May 10, 2023 | BDSX Biodesix Inc | Hutton Scott59 | President &CEO | Sell | 13,782 | $1.57 | $21,625.45 | -2.8% | -2.4% | -5.5% | |
| May 9, 2023 | WST West Pharmaceutical Services Inc | Green Eric Mark57 | President &CEO | Sell | 44,000 | $363.10 | $15,976,521.67 | -5.7% | +4.7% | +1.5% | |
| May 9, 2023 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 11,600 | $543.08 | $6,299,712.47 | -0.7% | +3.2% | +7.3% | |
| May 5, 2023 | OPK Opko Health, Inc. | Nabel Gary J. | Chief Innovation Officer | Buy | 460,245 | $1.83 | $840,898.92 | +0.8% | +1.1% | -29.0% | |
| May 5, 2023 | DHR Danaher Corp /de/ | Lohr Walter G51 | - | Sell | 3,490 | $240.88 | $840,685.16 | -22.4% | +6.2% | +2.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.